Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Schizophr Res. 2020 Apr 12;220:106–115. doi: 10.1016/j.schres.2020.03.048

Table 3.

Pooled prevalence of antipsychotic drug use during the pregnancy period in the Nordic countries by maternal and pregnancy characteristics.

Any antipsychotic Typical antipsychotic Atypical antipsychotic
Country (weight %) Total N Prevalence (95% CI)a N Prevalence (95% CI)a N Prevalence (95% CI)a
Pooled (100) 3,132,167 19,534 0.58 (0.58, 0.59) 11,566 0.32 (0.31, 0.33) 9,081 0.27 (0.26, 0.27)
Denmark (26.0) 813,360 2,858 0.35 (0.34, 0.36) 1,844 0.23 (0.22, 0.24) 1,269 0.16 (0.15, 0.16)
Iceland (1.9) 60,477 881 1.46 (1.36, 1.55) 504 0.83 (0.76, 0.91) 435 0.72 (0.65, 0.79)
Finland (18.7) 584,139 4,374 0.75 (0.73, 0.77) 977 0.17 (0.16, 0.18) 3,741 0.64 (0.62, 0.66)
Norway (20.6) 645,459 7,492 1.16 (1.13, 1.19) 6,162 0.95 (0.93, 0.98) 1,539 0.24 (0.23, 0.25)
Sweden (32.8) 1,028,732 3,929 0.38 (0.37, 0.39) 2,079 0.20 (0.19, 0.21) 2,097 0.20 (0.20, 0.21)
Parity
1 1,299,079 7,580 0.55 (0.54, 0.56) 4,497 0.30 (0.29, 0.31) 3,583 0.27 (0.26, 0.28)
2 1,004,582 5,177 0.47 (0.45, 0.48) 3,600 0.34 (0.33, 0.35) 1,782 0.16 (0.16, 0.17)
3 381,385 2,553 0.62 (0.60, 0.65) 1,781 0.41 (0.39, 0.43) 895 0.22 (0.21, 0.24)
≥4 169,324 1,604 0.92 (0.87, 0.96) 1,053 0.57 (0.53, 0.60) 658 0.38 (0.36, 0.41)
missing 277,797 2,620 0.93 (0.90, 0.97) 635 0.21 (0.19, 0.23) 2,163 0.21 (0.19, 0.23)
Smokingb
No 2,551,171 11,892 0.43 (0.42, 0.44) 7,411 0.24 (0.24, 0.25) 4,953 0.18 (0.18, 0.19)
Yes 341,726 5,123 1.46 (1.42, 1.50) 2,448 0.68 (0.65, 0.71) 3,198 0.86 (0.83, 0.89)
Missing 178,793 1,638 0.88 (0.84, 0.92) 1,203 0.62 (0.58, 0.65) 495 0.27 (0.24, 0.29)
Cohabitationb
Cohabiting 1,876,289 8,653 0.49 (0.48, 0.50) 3,930 0.20 (0.20, 0.21) 5,368 0.33 (0.32, 0.34)
Not cohabiting 516,888 2,721 0.50 (0.48, 0.52) 1,172 0.39 (0.38, 0.41) 1,750 0.65 (0.63, 0.66)
Missing 93,531 668 0.70 (0.65, 0.75) 302 0.36 (0.32, 0.39) 424 1.06 (1.03, 1.08)
Multi-fetal Pregnancy
No 3,077,982 19,231 0.58 (0.58, 0.59) 11,392 0.34 (0.33, 0.35) 8,939 0.27 (0.26, 0.27)
Yes 53,052 302 0.54 (0.48, 0.60) 174 0.31 (0.26, 0.36) 142 0.23 (0.19, 0.27)
Year of Birth
2000–2004d 323,511 852 0.26 (0.24, 0.27) 712 0.21 (0.20, 0.23) 179 0.23 (0.19, 0.27)
2005–2009 1,285,897 8,695 0.64 (0.62, 0.65) 6,457 0.44 (0.43, 0.45) 2,730 0.20 (0.20, 0.21)
2010–2017 1,522,759 9,987 0.61 (0.59, 0.62) 4,397 0.23 (0.22, 0.24) 6,172 0.37 (0.36, 0.38)

Note: The pregnancy period is defined as 90 days before the date of the last menstrual period to the date of birth.

a

Prevalence per 100 pregnancies weighted by population and 95% confidence intervals (CI)

b

Data on smoking available for Denmark, Finland, Norway, Sweden; Data on cohabitation available for Denmark, Iceland, Finland, Sweden; For Denmark ‘Cohabiting’ reflects marital status

c

Only Denmark and Iceland included births occurring in 2000–2004